Jean-Patrick Demonsang
Voorzitter bij Demonsang Consulting SAS
Actieve functies van Jean-Patrick Demonsang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Demonsang Consulting SAS | Voorzitter | - | - |
Loopbaan van Jean-Patrick Demonsang
Eerdere bekende functies van Jean-Patrick Demonsang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Directeur/Bestuurslid | 10-04-2014 | 22-06-2023 |
| Independent Dir/Board Member | 10-04-2014 | 22-06-2023 | |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Algemeen Directeur | 21-06-2010 | 01-01-2013 |
| Voorzitter | 01-09-1999 | 01-01-2013 | |
| President | 01-09-1999 | 01-01-2013 | |
Natixis Venture Sélection SA
 Natixis Venture Sélection SA Investment ManagersFinance Natixis Venture Selection SA seeks to invest in French companies operating in a wide range of sectors, it focuses on early and later venture capital stages. | Directeur/Bestuurslid | - | - |
| Genode Partners SAS | Algemeen Directeur | - | - |
| Parexi SAS | Voorzitter | - | - |
| G1j Ile De France | Voorzitter | - | - |
Orphan Synergy Europe-Pharma SA
 Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Directeur/Bestuurslid | 10-04-2014 | - |
| Independent Dir/Board Member | 10-04-2014 | - |
Opleiding van Jean-Patrick Demonsang
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Statistieken
Internationaal
| Frankrijk | 10 |
Operationeel
| Chairman | 4 |
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
Sectoraal
| Finance | 3 |
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Finance |
Natixis Venture Sélection SA
Natixis Venture Sélection SA Investment ManagersFinance Natixis Venture Selection SA seeks to invest in French companies operating in a wide range of sectors, it focuses on early and later venture capital stages. | Finance |
Orphan Synergy Europe-Pharma SA
Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Health Technology |
| Demonsang Consulting SAS | |
| G1j Ile De France | |
| Parexi SAS | |
| Genode Partners SAS |
